NCT03679598 · Interventional trial
Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency
Overall registry status Completed
Phase 2
Conditions Alpha-1 Antitrypsin Deficiency (AATD), Emphysema or COPD, Pi*ZZ, Pi*SZ, Pi*Null, Another Rare Phenotype/Genotype Known to be Associated With Either Low or Functionally Impaired AAT Including F or I Mutations
Delaware Valley sites
- Temple University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory